Javascript is required for this site to function correctly.
Please enable Javascript support.

Snapshots of MJFF Recently Awarded Grants

The Foundation supports research that will lead to the creation of better Parkinson's treatments. Here are some of the patient-relevant projects the Foundation has recently funded.

If you are looking for a specific project, please search our Funded Grants Database.

Generation of Specific LRRK2 Antibodies in Murine LRRK2 Knockout Models

Justus Daechsel, PhD
Institution: Mayo Clinic
MJFF Program: Non-program-specific Funding 2009
Accurate Drosophila Models of LRRK2-based Parkinson’s Disease

Robert Reenan, PhD
Institution: Brown University, MCB Department
MJFF Program: Rapid Response Innovation Awards 2009
Uncovering factors that prevent dopaminergic neuronal degeneration in a novel C. elegans model for Parkinson’s Disease using a high-throughput forward genetics approach

Maria Doitsidou, PhD
Institution: Columbia University Medical Center
MJFF Program: Rapid Response Innovation Awards 2009
Oliver Hobert, PhD
Institution: Columbia University Medical Center
MJFF Program: Rapid Response Innovation Awards 2009
Clinicogenetic Studies of LRRK2 G2019S in Tunisia

Matt Farrer, PhD
Institution: Mayo Clinic
MJFF Program: Non-program-specific Funding 2009
Fayçal Hentati, MD
Institution: National Institute of Neurology
MJFF Program: Non-program-specific Funding 2009
Maurice Freedman
Institution: Zaah Technologies
MJFF Program: Non-program-specific Funding 2009
Matthew Read, BSc
Institution: Prn
MJFF Program: Non-program-specific Funding 2009
DAT Imaging in Ashkenazi Jews LRRK2 Gene Carriers – A Consortium Proposal

Kenneth Marek, MD
Institution: The Institute for Neurodegenerative Disorders
MJFF Program: Non-program-specific Funding 2009
Next: Searchable Database of MJFF Awarded Grants
Print This Page Email This Page